Kraig Biocraft Laboratories, Inc. (KBLB)

KBLB Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	2.55	3.86	2.36	0.82	0.13
Short-Term Investments	0	0	0	0	0
Cash & Cash Equivalents	2.55	3.86	2.36	0.82	0.13
Cash Growth	-33.94%	64.02%	188.29%	553.40%	812.78%
Receivables	0	-0	0	0	0
Inventory	0.01	0.01	0	0	0
Other Current Assets	0.01	0.11	0.01	0	0.03
Total Current Assets	2.57	3.98	2.37	0.82	0.16
Property, Plant & Equipment	0.16	0.15	0.22	0.45	0.59
Long-Term Investments	0.49	0.44	0.44	0	0
Other Long-Term Assets	0	0	0	0	0
Total Long-Term Assets	0.66	0.59	0.66	0.46	0.59
Total Assets	3.23	4.57	3.02	1.28	0.75
Accounts Payable	0.93	0.54	5.83	5.4	4.71
Current Debt	1.76	1.75	2.27	1.98	0.81
Other Current Liabilities	6.2	5.78	0.07	0.07	0.07
Total Current Liabilities	8.89	8.07	8.16	7.45	5.58
Long-Term Debt	0.05	0.02	0.16	0.4	0.55
Total Long-Term Liabilities	0.05	0.02	0.16	0.4	0.55
Total Liabilities	8.94	8.09	8.32	7.85	6.14
Total Debt	1.81	1.77	2.42	2.38	1.37
Debt Growth	2.34%	-26.78%	1.58%	74.27%	324.60%
Common Stock	27.39	27.06	22.39	17.12	16.76
Retained Earnings	-49.69	-46.66	-42.81	-34.77	-29.8
Comprehensive Income	0.02	0.02	0.02	0.02	0.02
Shareholders' Equity	-5.71	-3.52	-5.3	-6.57	-5.39
Total Liabilities and Equity	3.23	4.57	3.02	1.28	0.75
Net Cash / Debt	0.74	2.09	-0.07	-1.57	-1.24
Net Cash / Debt Growth	-64.69%	-	-	-	-
Net Cash Per Share	0.00	0.00	-0.00	-0.00	-0.00
Working Capital	-6.31	-4.09	-5.8	-6.63	-5.43
Book Value Per Share	-0.01	-0.00	-0.01	-0.01	-0.01

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.